131 related articles for article (PubMed ID: 9824096)
1. Analysis of cell cycle regulators: p16INK4A, pRb, and CDK4 in low- and high-grade meningiomas.
Tse JY; Ng HK; Lo KW; Chong EY; Lam PY; Ng EK; Poon WS; Huang DP
Hum Pathol; 1998 Nov; 29(11):1200-7. PubMed ID: 9824096
[TBL] [Abstract][Full Text] [Related]
2. [Methylation and expression analysis of p16(INK4a) and RB genes in meningiomas].
Chen MN; Mao Q; Liu YH; Mao BY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Jun; 21(3):277-9. PubMed ID: 15192837
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas.
Burns KL; Ueki K; Jhung SL; Koh J; Louis DN
J Neuropathol Exp Neurol; 1998 Feb; 57(2):122-30. PubMed ID: 9600204
[TBL] [Abstract][Full Text] [Related]
4. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.
Nielsen GP; Burns KL; Rosenberg AE; Louis DN
Am J Pathol; 1998 Jul; 153(1):159-63. PubMed ID: 9665476
[TBL] [Abstract][Full Text] [Related]
5. Expression of the cell-cycle regulatory proteins (pRb, cyclin D1, p16INK4A and cdk4) in human endometrial cancer: correlation with clinicopathological features.
Semczuk A; Miturski R; Skomra D; Jakowicki JA
Arch Gynecol Obstet; 2004 Jan; 269(2):104-10. PubMed ID: 14648178
[TBL] [Abstract][Full Text] [Related]
6. Human pituitary adenomas infrequently contain inactivation of retinoblastoma 1 gene and activation of cyclin dependent kinase 4 gene.
Honda S; Tanaka-Kosugi C; Yamada S; Sano T; Matsumoto T; Itakura M; Yoshimoto K
Endocr J; 2003 Jun; 50(3):309-18. PubMed ID: 12940460
[TBL] [Abstract][Full Text] [Related]
7. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
[TBL] [Abstract][Full Text] [Related]
8. CDK4 gene amplification in osteosarcoma: reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons.
Wei G; Lonardo F; Ueda T; Kim T; Huvos AG; Healey JH; Ladanyi M
Int J Cancer; 1999 Jan; 80(2):199-204. PubMed ID: 9935200
[TBL] [Abstract][Full Text] [Related]
9. Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas.
Spanakis NE; Gorgoulis V; Mariatos G; Zacharatos P; Kotsinas A; Garinis G; Trigidou R; Karameris A; Tsimara-Papastamatiou H; Kouloukousa M; Manolis EN; Kittas C
Anticancer Res; 1999; 19(3A):1893-9. PubMed ID: 10470133
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of N-ras, p53, p16INK4a, p14ARF and CDK4 genes in primary human malignant mesotheliomas.
Papp T; Schipper H; Pemsel H; Bastrop R; Muller KM; Wiethege T; Weiss DG; Dopp E; Schiffmann D; Rahman Q
Int J Oncol; 2001 Feb; 18(2):425-33. PubMed ID: 11172613
[TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China.
Xing EP; Nie Y; Wang LD; Yang GY; Yang CS
Carcinogenesis; 1999 Jan; 20(1):77-84. PubMed ID: 9934853
[TBL] [Abstract][Full Text] [Related]
12. Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines.
Shapiro GI; Park JE; Edwards CD; Mao L; Merlo A; Sidransky D; Ewen ME; Rollins BJ
Cancer Res; 1995 Dec; 55(24):6200-9. PubMed ID: 8521414
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of alterations of the p18INK4c gene in human meningiomas.
Santarius T; Kirsch M; Nikas DC; Imitola J; Black PM
Neuropathol Appl Neurobiol; 2000 Feb; 26(1):67-75. PubMed ID: 10736068
[TBL] [Abstract][Full Text] [Related]
14. Alteration of pRb/p16/cdk4 regulation in human osteosarcoma.
Benassi MS; Molendini L; Gamberi G; Ragazzini P; Sollazzo MR; Merli M; Asp J; Magagnoli G; Balladelli A; Bertoni F; Picci P
Int J Cancer; 1999 Oct; 84(5):489-93. PubMed ID: 10502725
[TBL] [Abstract][Full Text] [Related]
15. Infrequent alterations of the p15, p16, CDK4 and cyclin D1 genes in non-astrocytic human brain tumors.
Sato K; Schäuble B; Kleihues P; Ohgaki H
Int J Cancer; 1996 May; 66(3):305-8. PubMed ID: 8621248
[TBL] [Abstract][Full Text] [Related]
16. Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas.
Pinyol M; Hernandez L; Cazorla M; Balbín M; Jares P; Fernandez PL; Montserrat E; Cardesa A; Lopez-Otín C; Campo E
Blood; 1997 Jan; 89(1):272-80. PubMed ID: 8978301
[TBL] [Abstract][Full Text] [Related]
17. Genetic alterations of p16INK4a and p14ARF genes in human bladder cancer.
Chang LL; Yeh WT; Yang SY; Wu WJ; Huang CH
J Urol; 2003 Aug; 170(2 Pt 1):595-600. PubMed ID: 12853838
[TBL] [Abstract][Full Text] [Related]
18. Mutation analysis of the pRb pathway in 2',3'-dideoxycytidine- and 1, 3-butadiene-induced mouse lymphomas.
Zhuang SM; Wiseman RW; Söderkvist P
Cancer Lett; 2000 May; 152(2):129-34. PubMed ID: 10773403
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas.
Maelandsmo GM; Flørenes VA; Hovig E; Oyjord T; Engebraaten O; Holm R; Børresen AL; Fodstad O
Br J Cancer; 1996 Apr; 73(8):909-16. PubMed ID: 8611425
[TBL] [Abstract][Full Text] [Related]
20. G1 control gene status is frequently altered in resectable non-small cell lung cancer.
Betticher DC; White GR; Vonlanthen S; Liu X; Kappeler A; Altermatt HJ; Thatcher N; Heighway J
Int J Cancer; 1997 Oct; 74(5):556-62. PubMed ID: 9355981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
